Canada markets closed

Cerevel Therapeutics Holdings, Inc. (CERE)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
41.22+0.09 (+0.22%)
At close: 04:00PM EST
41.16 -0.06 (-0.15%)
After hours: 07:38PM EST
Currency in USD

Valuation Measures4

Market Cap (intraday) 7.43B
Enterprise Value 7.12B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)27.22
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -17.94

Trading Information

Stock Price History

Beta (5Y Monthly) 1.38
52-Week Change 352.50%
S&P500 52-Week Change 315.38%
52 Week High 341.75
52 Week Low 319.59
50-Day Moving Average 324.99
200-Day Moving Average 326.80

Share Statistics

Avg Vol (3 month) 31.8M
Avg Vol (10 day) 36.44M
Shares Outstanding 5180.28M
Implied Shares Outstanding 6180.28M
Float 876.04M
% Held by Insiders 115.20%
% Held by Institutions 182.11%
Shares Short (Nov 14, 2023) 48.21M
Short Ratio (Nov 14, 2023) 49.04
Short % of Float (Nov 14, 2023) 412.16%
Short % of Shares Outstanding (Nov 14, 2023) 44.55%
Shares Short (prior month Oct 12, 2023) 47.41M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Sept 29, 2023


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-27.08%
Return on Equity (ttm)-89.69%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -409.53M
Net Income Avi to Common (ttm)-392.99M
Diluted EPS (ttm)-2.50
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)676.88M
Total Cash Per Share (mrq)3.76
Total Debt (mrq)473.44M
Total Debt/Equity (mrq)173.45%
Current Ratio (mrq)8.72
Book Value Per Share (mrq)1.73

Cash Flow Statement

Operating Cash Flow (ttm)-332.36M
Levered Free Cash Flow (ttm)-193.15M